Company announcementno 2024-07 | |
Completion of capital reduction in
As stated in company announcement no. 2024-06, it was decided at Demant A/S’ ordinary general meeting on
The capital reduction was published via the electronic information system of the
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal):
Number of voting rights: 221,089,792
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 www.demant.com | Other contacts: Peter Pudselykke, Head of Investor Relations |
Contacts
Henrik Axel Lynge Buchter , External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
- 2024-07 Completion of capital reduction.pdf
© Ritzau Denmark, source